BDR in pact to make Gilead drug for Cipla
Posted by
www.biotecnika.org
In late May, BDR had sought the approval of India's drug regulator to
make and sell remdesivir in India without entering into an arrangement
with Gilead. The Mumbai-based company has now signed a contract to
make the drug for Cipla, which is one of the licensed companies.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/bdr-in-pact-to-make-gilead-drug-for-cipla/articleshow/76127236.cms
Subscribe to:
Post Comments (Atom)
Post a Comment